Salivary levels of anticonvulsants: A practical approach to drug monitoring

John J. McAuliffe, Allan L. Sherwin, Ilo E. Leppik, Shirley A. Fayle, Charles E. Pippenger

Research output: Contribution to journalArticlepeer-review

110 Scopus citations

Abstract

Phenobarbital, phenytoin, carbamazepine, primidone, and ethosuximide were measured in saliva and plasma obtained simultaneously from 115 patients. A method to correct for the effect of salivary pH on phenobarbital concentration of saliva was developed. Salivary concentrations of these drugs were found to be equivalent to the plasma free drug and to correlate closely with the total plasma levels. Expressed as percent of total plasma drug, the salivary (S) and plasma free (P) concentrations were: phenytoin, S 11.1 ± 2.0 percent (mean ± SD), P 10.1 ± 2.4 percent (r = 0.97); carbamazepine, S 26.0 ± 2.4 percent, P 25.9 ± 3.4 percent (r = 0.97); phenobarbital, S 43.1 ± 5.2 percent, P 40.8 ± 7.9 percent (r = 0.91); primidone, S 75.4 ± 24.9 percent, P 66.4 ± 8.8 percent (r = 0.76). Ethosuximide was not bound by plasma proteins, and its plasma and salivary levels were equal.

Original languageEnglish (US)
Pages (from-to)409-413
Number of pages5
JournalNeurology
Volume27
Issue number5
DOIs
StatePublished - May 1977

Fingerprint Dive into the research topics of 'Salivary levels of anticonvulsants: A practical approach to drug monitoring'. Together they form a unique fingerprint.

Cite this